Kayothera, Inc. Strengthens Financial Position With $5.2 Million In Grant And Expanded Series A Funding, Bringing Total Financial Support To $14 Million
Round Type
Series A
PrincetonOtherBiotechnologyHealth CareTherapeuticsInvestors
Description
KayoThera, Inc. (“KayoThera”), an early-stage therapeutics company developing first-in-class, oral, small molecule inhibitors of the retinoid pathway, today announces the strengthening of its financial resources through multiple grant awards and expansion of its previously announced Series A financing. The expanded financing was led by Accelerator Life Science Partners (ALSP), who also provided Series A funding for KayoThera. With the additional $5.2 million in new equity investments, non-dilutive grant funding, and initial seed funding from the New Jersey Health Foundation, KayoThera’s total financial support to date is $14 million.
Who else raised in Therapeutics and Biotechnology around the same time
Companies in the same sectors as KayoThera, Inc. that raised within 45 days of this round, from Fundz verified event records.
- Innovac Therapeutics raised $18M (Funding Round) on September 1, 2023.
- Alpha Cognition raised $1.3M (Seed) on August 31, 2023.
- Lexeo Therapeutics raised an undisclosed amount (Corporate Round) on August 28, 2023.
- Rapport raised $150M (Series B) on August 24, 2023.
- Fore Biotherapeutics raised $75M (Series D) on August 24, 2023.
- Actimed Therapeutics raised $6.1M (Series A) on August 22, 2023.
Who to call at KayoThera, Inc., and when
A new round usually means KayoThera, Inc. is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day KayoThera, Inc. raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at KayoThera, Inc., from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at KayoThera, Inc.. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment KayoThera, Inc. raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Funding Insights
What this usually meansKayoThera, Inc. raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.